Monday , August 20 2018
Home / Letter From The Editor / Nov. 1, 2016

Nov. 1, 2016

Nov 1, 2016

daveThere have been three new classes of diabetes drugs that have changed the face of diabetes care over the past 7 years. Two of those are oral and one is an injectable, and they have been going head to head all that time. Now, rather than comparing them, clinicians are using them together. This week in our Homerun Slides we look at case histories on the use of two of these classes together and how patients can benefit.

Dave Joffe